Rate My Professor Chady Barkil

Chady Barkil serves as the Director of the Molecular Imaging and Therapy Research Unit (MITRU) at the South Australian Health and Medical Research Institute (SAHMRI) in Adelaide, Australia. MITRU is equipped with South Australia's sole cyclotron, a particle accelerator essential for producing radioactive tracers utilized in positron emission tomography (PET) scans and other diagnostic procedures. The unit specializes in the research, development, and Good Manufacturing Practice (GMP)-compliant production of radiopharmaceuticals, facilitating both clinical diagnostics and innovative research in molecular imaging and targeted radionuclide therapies. Under Barkil's direction, MITRU supports translational efforts to bridge laboratory discoveries with patient care, contributing to advancements in cancer treatment and other diseases through precise imaging and therapy agents.

Barkil has actively engaged in disseminating knowledge about radiopharmaceutical manufacturing and supply chains, appearing on the MTPConnect podcast to discuss nuclear medicines production and Australia's radiopharmaceuticals capabilities. He featured in SAHMRI's 'A Window on SAHMRI' podcast episode titled 'The Quiet Achievers Powering Patient Care' alongside Dr. Ed Robins, underscoring the unit's role in enabling PET scans and impacting patients, families, and communities. He presented on translational research and MITRU's contributions at the Adelaide NET Patient Forum organized by NeuroEndocrine Cancer Australia. Internationally, Barkil is documented as the contact and person in charge for the SAHMRI cyclotron in the International Atomic Energy Agency's Cyclotron Master List. His involvement extends to educational sessions, such as guest speaking at the Biomanufacturing Industry Doctoral Training Centre PhD+ program on current trends in the field, and collaborative events like SAHMRI's 10th anniversary celebrations with affiliates from the University of Adelaide. Through these activities, Barkil bolsters South Australia's biomedical research landscape, particularly in molecular imaging, therapy research, and radiopharmaceutical innovation.